Teva Pharmaceutical Industries Ltd (TEVA)
16.26
+0.26
(+1.59%)
USD |
NYSE |
May 10, 16:00
16.28
+0.02
(+0.15%)
After-Hours: 20:00
Teva Pharmaceutical Industries Total Assets (Quarterly): 42.77B for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 42.77B |
December 31, 2023 | 43.48B |
September 30, 2023 | 42.09B |
June 30, 2023 | 43.10B |
March 31, 2023 | 43.46B |
December 31, 2022 | 44.01B |
September 30, 2022 | 44.25B |
June 30, 2022 | 45.93B |
March 31, 2022 | 47.06B |
December 31, 2021 | 47.67B |
September 30, 2021 | 47.85B |
June 30, 2021 | 49.20B |
March 31, 2021 | 49.00B |
December 31, 2020 | 50.64B |
September 30, 2020 | 49.74B |
June 30, 2020 | 54.99B |
March 31, 2020 | 55.33B |
December 31, 2019 | 57.47B |
September 30, 2019 | 57.25B |
June 30, 2019 | 59.42B |
March 31, 2019 | 59.85B |
December 31, 2018 | 60.68B |
September 30, 2018 | 65.06B |
June 30, 2018 | 67.03B |
March 31, 2018 | 69.18B |
Date | Value |
---|---|
December 31, 2017 | 70.62B |
September 30, 2017 | 86.08B |
June 30, 2017 | 86.36B |
March 31, 2017 | 91.28B |
December 31, 2016 | 93.06B |
September 30, 2016 | 98.75B |
June 30, 2016 | 57.92B |
March 31, 2016 | 55.13B |
December 31, 2015 | 54.23B |
September 30, 2015 | 48.62B |
June 30, 2015 | 50.37B |
March 31, 2015 | 46.95B |
December 31, 2014 | 46.42B |
September 30, 2014 | 46.61B |
June 30, 2014 | 46.73B |
March 31, 2014 | 46.89B |
December 31, 2013 | 47.51B |
September 30, 2013 | 47.85B |
June 30, 2013 | 47.50B |
March 31, 2013 | 48.07B |
December 31, 2012 | 50.61B |
September 30, 2012 | 49.58B |
June 30, 2012 | 48.88B |
March 31, 2012 | 50.47B |
December 31, 2011 | 50.14B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
42.09B
Minimum
Sep 2023
59.42B
Maximum
Jun 2019
48.73B
Average
47.76B
Median
Total Assets (Quarterly) Benchmarks
Viatris Inc | 47.69B |
Alvotech | 950.09M |
AstraZeneca PLC | 102.29B |
Corcept Therapeutics Inc | 655.94M |
GSK PLC | 73.87B |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 35.23B |
Shareholders Equity (Quarterly) | 7.278B |
Debt to Equity Ratio | 2.699 |
Current Ratio | 0.8916 |
Net Debt Paydown Yield | 1.96% |